Ally Bridge Group (Ny) LLC Merus N.V. Transaction History
Ally Bridge Group (Ny) LLC
- $88.1 Million
- Q4 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Merus N.V. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 116,796 shares of MRUS stock, worth $5.38 Million. This represents 5.58% of its overall portfolio holdings.
Number of Shares
116,796
Previous 208,244
43.91%
Holding current value
$5.38 Million
Previous $10.4 Million
52.79%
% of portfolio
5.58%
Previous 7.39%
Shares
8 transactions
Others Institutions Holding MRUS
# of Institutions
202Shares Held
60.7MCall Options Held
111KPut Options Held
85.7K-
Rtw Investments, LP New York, NY4.17MShares$192 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$178 Million16.32% of portfolio
-
Wellington Management Group LLP Boston, MA3.5MShares$161 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$137 Million3.1% of portfolio
-
Samlyn Capital, LLC New York, NY2.67MShares$123 Million1.81% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.11B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...